Followers | 4054 |
Posts | 151817 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Tuesday, October 30, 2018 12:43:29 PM
just missed getting filled on this dip
I was bidding 7.70
it came down to 7.72
thats what I get for being cheap
I should have been @ 7.73
Recent DXR News
- Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:10:05 PM
- Daxor Corporation Appoints John L. Jefferies, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 05/30/2024 10:43:48 AM
- New Studies Prove the Clinical Benefits of Daxor’s Blood Volume (BVA-100TM) Diagnostic In Ambulatory Heart Failure Patients For Measurement of Congestion • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- DAXOR CORPORATION TO EXHIBIT AT THE MEDAXIOM CARDIOVASCULAR TRANSFORUM CONFERENCE SPRING’24 TO ADVANCE AWARENESS AND FURTHER ADOPTION OF DAXOR’S BLOOD VOLUME DIAGNOSTIC (BVA-100™) • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Daxor Corporation Announces New Hospital Account at Leading Chicago Hospital • GlobeNewswire Inc. • 04/10/2024 12:00:00 PM
- Daxor Corporation to Exhibit at the American College of Cardiology for ACC.24 • GlobeNewswire Inc. • 04/01/2024 12:00:00 PM
- Daxor Corporation Acquires Volumex® and Megatope® From Its Existing Supplier Along With Glofil® to Enhance Existing Suite of Diagnostics • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Daxor Corporation to Hold Investor Call Discussing Fiscal Year 2023 Financial Results and Corporate Update on March 25, 2024 • GlobeNewswire Inc. • 03/22/2024 12:00:00 PM
- Daxor Corporation Reports Increase in NAV to $7.08 Per Share and 31.8 Percent Increase in Unaudited Revenue of Operating Division for the Year Ended December 31, 2023 • GlobeNewswire Inc. • 03/18/2024 06:18:00 PM
- Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders • GlobeNewswire Inc. • 03/18/2024 06:18:00 PM
- Daxor Announces Sales to Three New Hospitals Furthering Expansion of Its User Base • GlobeNewswire Inc. • 03/11/2024 12:00:00 PM
- Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend] • Edgar (US Regulatory) • 03/08/2024 06:49:31 PM
- Multi-Center Study Presented by Duke at Heart Failure Therapeutics Conference Highlights Daxor’s Unique Clinical Utility for Heart Failure Patients • GlobeNewswire Inc. • 03/08/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:18:32 PM
- Form NT-NCSR/A - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report): [Amend] • Edgar (US Regulatory) • 02/29/2024 10:28:32 PM
- Form NT-NCSR - Notice under Exchange Act Rule 12b-25 of inability to timely file Form N-CSR (annual or semi-annual report) • Edgar (US Regulatory) • 02/29/2024 09:15:19 PM
- Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- Daxor Corporation Starts 2024 with Ongoing Growth in New Blood Volume Analyzer Acquisitions • GlobeNewswire Inc. • 02/12/2024 01:00:00 PM
- Daxor Corporation Closes Q4 2023 with Growth in New Sales to Hospital Systems and Increased Utilization of its BVA-100® Blood Volume Diagnostic Across the U.S. at Existing Accounts • GlobeNewswire Inc. • 02/07/2024 01:00:00 PM
- Daxor Corporation to Exhibit at the Society of Nuclear Medicine and Molecular Imaging Mid-Winter and American College Nuclear Medicine Annual Meeting • GlobeNewswire Inc. • 01/29/2024 01:00:00 PM
- Daxor Corporation to Exhibit at the Society for Critical Care Medicine 2024 Critical Care Congress • GlobeNewswire Inc. • 01/16/2024 01:00:00 PM
- DAXOR AWARDED ADDITIONAL NEW PATENT FOR SMART BLOOD VOLUME GUIDANCE TECHNOLOGY TO IMPROVE TREATMENT AND OUTCOMES • GlobeNewswire Inc. • 01/09/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:52:42 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM